Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Indian (NIFTY) Healthcare Services Industry Analysis

UpdatedFeb 22, 2026
DataAggregated Company Financials
Companies89
  • 7D1.0%
  • 3M-5.1%
  • 1Y16.9%
  • YTD0.7%

Over the last 7 days, the Healthcare Services industry has remained flat, although notably Max Healthcare Institute gained 3.3%. As for the the longer term, the industry is up 17% over the past 12 months. As for the next few years, earnings are expected to grow by 30% per annum.

Industry Valuation and Performance

Has the Indian Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sun, 22 Feb 2026₹5.8t₹979.6b₹95.0b37.6x60.5x5.9x
Tue, 20 Jan 2026₹5.6t₹929.9b₹93.5b39.7x59.4x6x
Thu, 18 Dec 2025₹5.6t₹928.2b₹93.3b40.3x60x6x
Sat, 15 Nov 2025₹5.8t₹899.6b₹87.1b39.9x66.8x6.5x
Mon, 13 Oct 2025₹6.0t₹871.0b₹82.7b44.1x73.1x6.9x
Wed, 10 Sep 2025₹5.9t₹860.5b₹81.0b45.5x72.3x6.8x
Fri, 08 Aug 2025₹5.8t₹835.1b₹76.9b46.4x74.9x6.9x
Sun, 06 Jul 2025₹5.7t₹826.7b₹76.2b49.4x75.1x6.9x
Tue, 03 Jun 2025₹5.2t₹827.2b₹76.3b44.9x68.7x6.3x
Thu, 01 May 2025₹5.1t₹799.2b₹74.4b39.2x68.9x6.4x
Sat, 29 Mar 2025₹5.0t₹798.3b₹73.7b39.1x68.2x6.3x
Mon, 24 Feb 2025₹4.7t₹798.3b₹73.7b37x64x5.9x
Wed, 22 Jan 2025₹4.9t₹751.4b₹69.7b44.6x69.8x6.5x
Fri, 20 Dec 2024₹5.2t₹751.4b₹69.7b44.4x74x6.9x
Sun, 17 Nov 2024₹4.7t₹748.6b₹69.7b42.3x68x6.3x
Tue, 15 Oct 2024₹4.7t₹720.0b₹67.6b45.7x69x6.5x
Thu, 12 Sep 2024₹4.6t₹720.1b₹67.6b44.9x67.5x6.3x
Sat, 10 Aug 2024₹4.3t₹708.6b₹65.9b47.6x65.1x6.1x
Mon, 08 Jul 2024₹4.2t₹696.9b₹63.3b49x66.6x6x
Wed, 05 Jun 2024₹3.8t₹696.5b₹63.1b39.6x60.1x5.4x
Fri, 03 May 2024₹4.0t₹772.8b₹60.6b38.9x65.8x5.2x
Sun, 31 Mar 2024₹4.0t₹772.7b₹60.6b37.6x65.7x5.2x
Tue, 27 Feb 2024₹4.2t₹766.9b₹60.0b44.2x69.8x5.5x
Thu, 25 Jan 2024₹3.8t₹708.4b₹55.9b43.2x67.8x5.4x
Sat, 23 Dec 2023₹3.5t₹703.0b₹55.3b40.7x63.1x5x
Mon, 20 Nov 2023₹3.3t₹702.3b₹55.3b39.6x60.4x4.8x
Wed, 18 Oct 2023₹3.1t₹675.8b₹55.9b45.5x56.2x4.7x
Fri, 15 Sep 2023₹3.0t₹665.9b₹54.9b43.4x55.1x4.5x
Sun, 13 Aug 2023₹2.8t₹658.6b₹55.4b41.4x51.2x4.3x
Tue, 11 Jul 2023₹2.9t₹630.5b₹54.1b41.4x54.2x4.7x
Thu, 08 Jun 2023₹2.7t₹629.2b₹54.0b38x49.6x4.3x
Sat, 06 May 2023₹2.4t₹599.2b₹49.6b33.1x48.2x4x
Mon, 03 Apr 2023₹2.3t₹599.3b₹49.7b31.3x45.8x3.8x
Wed, 01 Mar 2023₹2.3t₹590.3b₹50.4b35.9x45x3.8x
Price to Earnings Ratio

45x


Total Market Cap: ₹2.3tTotal Earnings: ₹50.4bTotal Revenue: ₹590.3bTotal Market Cap vs Earnings and Revenue0%0%0%
Indian Healthcare Services Industry Price to Earnings3Y Average 63.6x202420252026
Current Industry PE
  • Investors are pessimistic on the Indian Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 60.5x which is lower than its 3-year average PE of 63.6x.
  • The industry is trading close to its 3-year average PS ratio of 5.7x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have grown 24% per year over the last three years.
  • Revenues for these companies have grown 18% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Indian Healthcare industry?

IN Market0.28%
Healthcare0.70%
Healthcare Services0.99%
Healthcare Facilities1.32%
Managed Healthcare0%0
Healthcare Services-0.93%
Healthcare Distributors-3.51%
Industry PE
  • Investors are most optimistic about the Healthcare Facilities industry, which is trading close to its 3-year average PE ratio of 64.4x.
    • Analysts are expecting annual earnings growth of 30.9%, which is higher than its past year's earnings growth of 17.6% per year.
  • Investors are most pessimistic about the Healthcare Distributors industry, which is trading below its 3-year average of 61.8x.
Forecasted Growth
  • Analysts are most optimistic on the Healthcare Distributors industry, expecting annual earnings growth of 36% over the next 5 years.
  • This is better than its past earnings growth rate of 25% per year.
  • In contrast, the Healthcare Services industry is expected to see its earnings grow by 22% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
543220 Max Healthcare Institute₹1.09k3.3%
+₹33.5b		7.7%PE74.6x
ASTERDM Aster DM Healthcare₹630.805.2%
+₹16.0b		52.0%PE99.7x
APOLLOHOSP Apollo Hospitals Enterprise₹7.62k1.0%
+₹10.5b		20.5%PE60.8x
PARKHOSPS Park Medi World₹184.375.0%
+₹3.8b		n/aPE30.5x
YATHARTH Yatharth Hospital & Trauma Care Services₹720.305.1%
+₹3.4b		87.1%PE41.5x

Latest News

JSLL
₹689.80
Jeena Sikho Lifecare
7D
-1.2%
1Y
92.9%

JSLL: Higher Margin Outlook Will Support Future Upside Potential

Analysts have lifted their price target for Jeena Sikho Lifecare from ₹950 to ₹1,200, citing updated assumptions for revenue growth, higher profit margins, and a lower future P/E multiple in their refreshed valuation model. What's in the News A board meeting is scheduled on Feb 7, 2026 to review unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025, along with the limited review report, and to consider other items with the chairperson's approval (company filing).
YATHARTH
₹720.30
Yatharth Hospital & Trauma Care Services
7D
5.1%
1Y
87.1%

YATHARTH: Upcoming Meetings Will Support Confidence In Long Term Upside Potential

Analysts have trimmed their price target on Yatharth Hospital & Trauma Care Services from ₹935 to ₹931.25, reflecting updated assumptions on revenue growth, profit margins and future P/E multiples while keeping the discount rate unchanged. What's in the News Board meeting scheduled for Feb 05, 2026, at 13:10 Indian Standard Time to consider and approve the unaudited standalone and consolidated financial results for the quarter ended Dec 31, 2025 (Key Developments).
KIMS
₹692.50
Krishna Institute of Medical Sciences
7D
0.8%
1Y
29.3%

KIMS: Fair View Will Weigh Postal Ballot Risks Against Margin And P/E Shifts

Analysts now set their price target for Krishna Institute of Medical Sciences at ₹650, reduced from a previous fair value estimate of ₹656.16, reflecting updates to their assumptions on the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Board meeting scheduled on Feb 06, 2026 to review and approve unaudited standalone and consolidated financial results for the third quarter and nine months ended Dec 31, 2025 (Key Developments).
FORTIS
₹921.00
Fortis Healthcare
7D
0.5%
1Y
48.7%

Fortis Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models

Feb 18
Fortis Healthcare Limited Just Missed Earnings - But Analysts Have Updated Their Models
543220
₹1,088.10
Max Healthcare Institute
7D
3.3%
1Y
7.7%

543220: Upcoming Board Decisions On Expansion Will Support Stronger Long-Term Upside Potential

Analysts have reduced their price target for Max Healthcare Institute from ₹1,550 to ₹1,500, reflecting updated views on slightly adjusted long term assumptions for revenue growth, profit margins, the discount rate and future P/E levels. What's in the News Board meeting scheduled for Feb 5, 2026 at 11:05 IST to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended Dec 31, 2025 (company filing) The same Feb 5, 2026 board meeting will also review an amendment to the existing services agreement related to additional beds at Max Super Speciality Hospital, Dwarka (company filing) Board meeting set for Dec 18, 2025 at 10:30 IST to review a proposal to enter into a share purchase agreement for acquisition of 100% equity stake in Yerawada Properties Private Limited (company filing) The Dec 18, 2025 board agenda also includes consideration of other matters that may be placed before the board (company filing) Valuation Changes Fair Value: trimmed from ₹1,550 to ₹1,500, representing a modest cut to the indicative valuation level used in the model.
ASTERDM
₹630.80
Aster DM Healthcare
7D
5.2%
1Y
52.0%

ASTERDM: Upcoming ESOP Plan And Rare Disease Care Will Support Bullish Outlook

Analysts have trimmed their fair value estimate for Aster DM Healthcare from ₹759.67 to ₹715.67. They pointed to updated assumptions around revenue growth, profit margins and future P/E that they see as better reflecting the current risk profile and earnings potential.
VIJAYA
₹1,008.90
Vijaya Diagnostic Centre
7D
2.1%
1Y
1.5%

Here's What Analysts Are Forecasting For Vijaya Diagnostic Centre Limited (NSE:VIJAYA) After Its Third-Quarter Results

Feb 17
Here's What Analysts Are Forecasting For Vijaya Diagnostic Centre Limited (NSE:VIJAYA) After Its Third-Quarter Results
ENTERO
₹1,079.20
Entero Healthcare Solutions
7D
-6.0%
1Y
-18.0%

Entero Healthcare Solutions Limited Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next

Feb 16
Entero Healthcare Solutions Limited Just Missed EPS By 25%: Here's What Analysts Think Will Happen Next
APOLLOHOSP
₹7,615.50
Apollo Hospitals Enterprise
7D
1.0%
1Y
20.5%

Analyst Estimates: Here's What Brokers Think Of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Third-Quarter Report

Feb 13
Analyst Estimates: Here's What Brokers Think Of Apollo Hospitals Enterprise Limited (NSE:APOLLOHOSP) After Its Third-Quarter Report
NEPHROPLUS
₹558.85
Nephrocare Health Services
7D
-2.4%
1Y
n/a
JLHL
₹1,211.70
Jupiter Life Line Hospitals
7D
-2.3%
1Y
-18.7%

JLHL: Upcoming Results Will Clarify Margin Pressures Behind Bullish View

Analysts have trimmed their price target for Jupiter Life Line Hospitals to ₹1,614.80 from ₹1,754.80, reflecting updated views that combine slightly higher revenue growth assumptions with lower profit margins and a reduced future P/E multiple. What's in the News A board meeting is scheduled on January 30, 2026 to consider, review and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (company filing).
AGARWALEYE
₹445.90
Dr. Agarwal's Health Care
7D
-2.0%
1Y
8.1%
MEDANTA
₹1,130.00
Global Health
7D
-0.8%
1Y
-8.5%

MEDANTA: New Noida Hospital And Modest Repricing Will Shape A Balanced Outlook

Analysts now place Global Health's price target at $1,100, up modestly from $1,086.88, citing updated assumptions around a slightly lower discount rate, adjusted revenue growth expectations, a higher projected profit margin, and a reduced future P/E multiple. What's in the News A board meeting is scheduled for February 4, 2026, to consider and approve unaudited financial results for the third quarter and nine months ended December 31, 2025.
METROPOLIS
₹1,860.10
Metropolis Healthcare
7D
-4.5%
1Y
12.6%

METROPOLIS: Genomics Expansion And Bonus Share Plans Will Shape Balanced Outlook

Analysts have raised their fair value estimate for Metropolis Healthcare from ₹1,655 to about ₹1,846, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E levels. What's in the News A board meeting is scheduled for February 4, 2026, to consider and approve unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, and to consider issuance of bonus shares, subject to shareholder approval (Key Developments).
523323
₹5,303.40
Kovai Medical Center and Hospital
7D
-1.7%
1Y
-13.5%
PARKHOSPS
₹184.37
Park Medi World
7D
5.0%
1Y
n/a